CCR7 and hepatocellular carcinoma: In this study, we systematically administered VEGF-C to orthotopic HCC mouse models, which promoted intratumoral lymphangiogenesis to provide pathways for CCR7+ monocytes, CCR7+ MΦs, and CCR7+ T cells to enter the tumor.